NextPlat (NXPL) Tax Rate (2017 - 2026)
NextPlat's (NXPL) quarterly Tax Rate came in at 50.0% in Q2 2026, down 4824.0% year-over-year from 1.06% in Q2 2025, and down 218.04% quarter-over-quarter from 42.36% in Q4 2025.
Powered by 
Analysis
NextPlat (NXPL) Tax Rate (2017 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Tax Rate for 8 consecutive years, with 50.0% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Tax Rate fell 4824.0% year-over-year to 50.0% in Q2 2026; TTM through Jun 2026 was 25.4%, a 1343.0% increase from a year earlier, with the FY2025 full-year figure at 21.0%, up 1366.0% from the prior year.
- Tax Rate was 50.0% for Q2 2026 at NextPlat, down from 42.36% in the prior quarter.
- Over five years, Tax Rate peaked at 77.19% in Q4 2022 and troughed at 50.0% in Q2 2026.
- A 5-year average of 11.39% and a median of 0.47% in 2025 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate tumbled 5872 bps in 2023 and surged 4749 bps in 2024, its largest moves.
- Over 5 years, Tax Rate stood at 77.19% in 2022, then slumped by 76 bps to 18.47% in 2023, then surged by 257 bps to 65.97% in 2024, then tumbled by 36 bps to 42.36% in 2025, then tumbled by 218 bps to 50.0% in 2026.
- The last three Tax Rate figures came in at 50.0% (Q2 2026), 42.36% (Q4 2025), and 1.18% (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -26.59% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -85.63% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 21.32% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 1.94% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 25.29% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 33.43% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 0.09% |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 21.26% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 2.08% |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | -50.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -50.00% |
| Dec 31, 2025 | 42.36% |
| Sep 30, 2025 | 1.18% |
| Jun 30, 2025 | -1.76% |
| Mar 31, 2025 | -0.47% |
| Dec 31, 2024 | 65.97% |
| Sep 30, 2024 | -0.59% |
| Jun 30, 2024 | -0.19% |
| Mar 31, 2024 | -1.61% |
| Dec 31, 2023 | 18.47% |
| Sep 30, 2023 | -0.66% |
| Jun 30, 2023 | -1.80% |
| Dec 31, 2022 | 77.19% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | -0.20% |
| Dec 31, 2018 | 0.06% |
| Sep 30, 2018 | -2.82% |
| Dec 31, 2017 | 0.90% |
| Sep 30, 2017 | -8.35% |